Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)
This clinical trial update summarizes results from an observational study of tocilizumab (RoActemra/Actemra) in real-world rheumatoid arthri…
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Metal Ions in Ceramic on Metal Total Hip Arthroplasty
The ClinicalTrials.gov update indicates a completed study evaluating metal ion exposure in ceramic-on-metal total hip arthroplasty with resu…
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis
This completed clinical trial update describes therapeutic strategies for rheumatoid arthritis patients treated with methotrexate.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: A Study in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial in rheumatoid arthritis completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: A Study of LY2439821 in Rheumatoid Arthritis [Phase 1]
A Phase 1 clinical trial of LY2439821 in rheumatoid arthritis has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: A Study in Rheumatoid Arthritis [Phase 1]
A Phase 1 clinical trial in rheumatoid arthritis sponsored by Eli Lilly and Company has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis [Phase 1]
Phase 1 clinical trial updating the use of human umbilical cord mesenchymal stem cells for rheumatoid arthritis. The study status is current…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) [Phase 3]
Phase 3 trial evaluating secukinumab in rheumatoid arthritis patients with inadequate response to anti-TNF therapy assessed efficacy at 24 w…
-
CLINICAL_TRIALS research · 2016-05-23Clinical Trial Update: RETRO (REduction of Therapy in RA Patients in Ongoing Remission) [Phase 3]
A Phase 3 trial named RETRO investigates reducing therapy in rheumatoid arthritis patients who are in ongoing remission. The study status is…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Acute Effect of Resistance Training in Inflammatory Markers in Women With Rheumatoid Arthritis [Phase 4]
Phase 4 trial assessing the acute effects of resistance training on inflammatory markers in women with rheumatoid arthritis; study completed…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Trial of a Physical Activity Intervention for RA Fatigue [NA]
This completed clinical trial evaluated a physical activity program to reduce fatigue in individuals with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Korean Post-marketing Surveillance for Orencia®
The document reports the completion of a Korean post-marketing surveillance study of Orencia (abatacept) for rheumatoid arthritis. It indica…
-
CLINICAL_TRIALS withdrawal · 2016-05-11Clinical Trial Update: Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis [Phase 4]
Phase 4 trial evaluating abatacept (Orencia) effects on apoptosis of T cells, B cells, and antigen-presenting cells in rheumatoid arthritis;…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
A non-interventional study of tocilizumab (RoActemra/Actemra) in adults with moderate to severe rheumatoid arthritis has completed and resul…
-
FDA approval · 2016-05-09FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
The FDA approved a supplemental application for Tolmetin sodium submitted by Atland Pharmaceuticals, LLC under ANDA073393.
-
FDA approval · 2016-05-09FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for tolmetin sodium submitted by Atland Pharmaceuticals, LLC.
-
FDA approval · 2016-05-09FDA Approved: ETODOLAC — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for etodolac from ANI Pharmaceuticals, Inc., granting regulatory approval for a change to the produc…
-
FDA approval · 2016-05-09FDA Approved: NABUMETONE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for nabumetone submitted by Chartwell RX, LLC.
-
FDA approval · 2016-05-09FDA Approved: SULINDAC — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for sulindac from Actavis Pharma, Inc.
-
FDA approval · 2016-05-09FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for diclofenac sodium from Aurobindo Pharma Limited.
-
FDA approval · 2016-05-09FDA Approved: NABUMETONE — Supplemental Application (ScieGen Pharmaceuticals Inc)
FDA approved a supplemental application for Nabumetone from ScieGen Pharmaceuticals Inc. The action updates the product's labeling based on …
-
FDA approval · 2016-05-09FDA Approved: INDOMETHACIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's supplemental application for INDOMETHACIN, marking an approved modification to the product under an ANDA.
-
FDA approval · 2016-05-09FDA Approved: INDOMETHACIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for Indomethacin, resulting in updated labeling for the product.
-
FDA approval · 2016-05-09FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved a supplemental application for etodolac submitted by Taro Pharmaceuticals U.S.A., Inc.
-
FDA approval · 2016-05-09FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
FDA approved a supplemental application for Naproxen submitted by Zameer Pharmaceuticals LLC.